{"title": "", "body": "son similares en apariencia a las colonias de Nocardia: secas, rugosas y, por lo general, de color blanco o amarillo; sin embargo algunas se pueden volver marron\u00e1ceas, rosas, naranjas o rojas despu\u00e9s de varios d\u00edas en las placas de cultivo. Las distintas especies de Gordonia pueden ser de crecimiento lento, por lo que las placas deben incubarse al menos durante 5 d\u00edas 8 .\n\nEn la bibliograf\u00eda consultada, no hemos encontrado ning\u00fan caso descrito de infecci\u00f3n cut\u00e1nea por G. araii, aunque s\u00ed por G. terrae en un chico de 15 a\u00f1os, siendo la v\u00eda de entrada de la infecci\u00f3n similar a nuestro caso, el pinchazo con una espina 9 .\n\nEn la literatura se expone que no existe un enfoque est\u00e1ndar para el tratamiento de Gordonia, y que en muchas ocasiones las infecciones provocadas por estas especies no son informadas, seguramente debido a que no es posible su completa identificaci\u00f3n mediante m\u00e9todos convencionales. As\u00ed, ser\u00eda recomendable apoyarse en los laboratorios de referencia para lograr la identificaci\u00f3n de Gordonia y disponer de paneles de sensibilidad antibi\u00f3tica y duraci\u00f3n del tratamiento, para promover el diagn\u00f3stico, tratamiento y manejo cl\u00ednico de este tipo de infecciones.\n\nAgradecemos al Dr. Juan Antonio S\u00e1ez Nieto y a la Dra. Gema Carrasco, del Laboratorio de Taxonom\u00eda Bacteriana del Centro Nacional de Microbiolog\u00eda del Instituto de Salud Carlos III, su colaboraci\u00f3n en la identificaci\u00f3n de la bacteria.\n\nCristina Mu\u00f1oz-Pe\u00f1a a, * , Mar\u00eda Jos\u00e9 Oca\u00f1a-Cano b , Carmen Amores-Antequera c y Purificaci\u00f3n Cantudo-Mu\u00f1oz c a Unidad de Gesti\u00f3n Cl\u00ednica de Laboratorio, Hospital Universitario San Agust\u00edn, Linares, Ja\u00e9n, Espa\u00f1a b Unidad de Dermatolog\u00eda y Venereolog\u00eda, Hospital Universitario San Agust\u00edn, Linares, Ja\u00e9n, Espa\u00f1a c Unidad de Gesti\u00f3n Cl\u00ednica de Laboratorio, Unidad de Microbiolog\u00eda, Hospital Universitario San Agust\u00edn, Linares, Ja\u00e9n, Espa\u00f1a * Autor para correspondencia. \n\nDear Editor, NICE guidance in 2009 recommended oseltamivir treatment to all hospitalized children with suspected flu in the epidemic weeks, based on the possibility of influenza infection in children with compatible symptoms, is about 58%. 1 Recognizing that this may be overestimating the rate of influenza, they recommend further research into the probability that an influenza-like illness is true influenza. Since then, the recommendations have remained virtually unchanged. 2 The American Academy of Pediatrics (AAP) has also, this year, recommended treatment for all hospitalized children. 3 Rapid detection influenza tests have moderate sensitivity (50-70%). Therefore, antiviral treatment has been recommended even in cases with negative laboratory results. Oseltamivir has demonstrated to reduce the duration of symptoms, especially if it is administrated in the first 48 h of the illness with mild or inexistent \u0b1d This study has been partially supported by FIS (Fondo de Investigaciones Sanitarias -Spanish Health Research Fund) Grants N \u2022 : PI06/0532, PI09/00246, and PI12/01291. side effects. Its role to prevent complications is not enough proven. Summarizing, emergence of antiviral resistance is an important clinical and public health concern. 4 In the Pediatric Department at the Severo-Ochoa Hospital in Spain, we conducted a prospective study of viral etiology of respiratory infection during seven consecutive seasons. Between December and February each season (12 weeks that included the epidemic peak), all children under 14 years hospitalized with criteria of suspected flu (febrile syndrome, upper or lower respiratory tract infection, bronchiolitis, wheezing episodes or pneumonia), were included in the study. In the 2009-10 season, patients were recruited from September to December, coinciding with the H1N1 pandemic. A total of 1612 cases were analyzed. Polymerase chain reaction for 17 respiratory viruses in nasopharyngeal aspirate was performed in the Respiratory Virus and Influenza Unit at the National Microbiology Center (ISCIII, Madrid, Spain).\n\nInfluenza viruses were detected in the 5.6-12% of cases, depending on the season, with the highest incidence corresponding to the H1N1 pandemic season (Fig. 1) . The proportion of different viruses detected is shown in Table 1 , being respiratory syncytial virus the most frequent. Following the current recommendations, 1477 children without influenza virus confirmed by laboratory, would had been treated with oseltamivir.\n\nAs other authors, we think that the greater value of using oseltamivir is to ensure it remains an effective defense against future seasonal and pandemic influenza viruses. Careful monitoring of levels of viral resistance in the circulating viruses combined with Table 1 Viruses detected by polymerase chain reaction in hospitalized children in the flu epidemic weeks. Patients  229  341  314  248  206  117  157  RSV  121  102  99  121  87  68  89  Rhinovirus  64  118  63  56  61  27  44  Human bocavirus  24  41  45  33  16  7  7  Adenovirus  17  28  43  16  17  8  19  Parainfluenza (1, 2 the further development of new anti-influenza drugs might be the best way for control. 5 Based on our personal experience, we recommend making an effort to improve diagnosis in children with suspected influenza, performing molecular techniques or a rapid diagnostic test with high sensitivity, 6 especially in children with risk factors and children requiring hospitalization. This may help to guide treatment with oseltamivir to patients who really need it.\n\nEvaluation of combined use of the MALDI-TOF and GenomEra MRSA/SA assay for the direct detection of methicillin resistance in Staphylococcus aureus from positive blood culture bottles\n\nEvaluaci\u00f3n del uso combinado de ensayo de MALDI-TOF y Genomera MRSA/SA para la detecci\u00f3n directa de la resistencia a la meticilina en Staphylococcus aureus de botellas de hemocultivo positivo\n\nStaphylococcus aureus bacteremia has been associated with high mortality rates, prolonged hospitalization and increased economic cost. Delay in the initiation of appropriate antimicrobial therapy is known to be an important determinant in clinical outcomes. Therefore, rapid identification of Staphylococcal species and susceptibility profiles in patients with bacteremia assist in the early optimization of therapy that would have a positive clinical impact. [1] [2] The aim of this study is to evaluate the GenomEra MRSA/SA assay in combination with MALDI-TOF MS for rapid detection of MRSA and MSSA in positive blood culture bottles.\n\nThe GenomEra MRSA/SA Diagnose (Abacus Diagnostica, Oy, Finland) is a fully automated closed tube PCR assay that simultaneously detects S. aureus specific DNA and a sequence within the mecA gene encoding for methicillin resistance with timeresolved fluorescence labels. 3 The sequence of the SA marker has not yet been published, but according to the manufacturer, it"}